Letter to the Editor: Predicting mortality after transjugular intrahepatic portosystemic shunt in older adult patients with cirrhosis-Does novelty supplant the standard?
- PMID: 36169940
- DOI: 10.1002/hep.32811
Letter to the Editor: Predicting mortality after transjugular intrahepatic portosystemic shunt in older adult patients with cirrhosis-Does novelty supplant the standard?
Comment on
-
Mortality after transjugular intrahepatic portosystemic shunt in older adult patients with cirrhosis: A validated prediction model.Hepatology. 2023 Feb 1;77(2):476-488. doi: 10.1002/hep.32704. Epub 2022 Aug 17. Hepatology. 2023. PMID: 35921493
References
-
- Vizzutti F, Celsa C, Calvaruso V, Enea M, Battaglia S, Turco L, et al. Mortality after transjugular intrahepatic portosystemic shunt in older adult patients with cirrhosis: a validated prediction model. Hepatology. 2022 Aug 3. https://doi.org/10.1002/hep.32704 . [Epub ahead of print] - DOI
-
- Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PCJ. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology. 2003;31:864–71.
-
- Bettinger D, Sturm L, Pfaff L, Hahn F, Kloeckner R, Volkwein L, et al. Refining prediction of survival after TIPS with the novel Freiburg index of post‐TIPS survival. J Hepatol. 2021;74:1362–72.
-
- Lai JC, Tandon P, Bernal W, Tapper EB, Ekong U, Dasarathy S, et al. Malnutrition, frailty, and sarcopenia in patients with cirrhosis: 2021 Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology. 2021;74(3):1611–44.
-
- Bai YW, Liu JC, Yang CT, Wang YL, Wang CY, Ju SG, et al. Inclusion of sarcopenia improves the prognostic value of MELD score in patients after transjugular intrahepatic portosystemic shunt. Eur J Gastroenterol Hepatol. 2022;34(9):948–55.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources